Vulnerable Plaque, CABG Patients Would Expand Stent Candidate Pool
This article was originally published in The Gray Sheet
Executive Summary
Interventional cardiology device makers are developing new patient populations now that drug-eluting stents are shown to virtually eliminate restenosis